Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. HALDOL decanoate 50 and HALDOL decanoate 100 are intended for use in schizophrenic patients who require prolonged parenteral antipsychotic therapy. Thes...
The following adverse reactions relating to the active moiety haloperidol have been identified during postapproval use of haloperidol or haloperidol decanoate. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency...
1 double-blind, active comparator-controlled trial with fluphenazine decanoate. 2 trials comparing the decanoate formulation to oral haloperidol. 9 open-label trials. 1 dose-response trial. Nervous System Disorders:Akinesia, Cogwheel rigidity, Masked facies. ...